|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2001-6-12
|
|
pubmed:abstractText |
We sought to evaluate the ability of type 5 phosphodiesterase (PDE5) inhibitors to augment the antithrombotic effects of inhaled nitric oxide (NO) in a canine model of platelet-mediated coronary thrombosis after thrombolysis.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0735-1097
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
37
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1981-8
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:11401142-Administration, Inhalation,
pubmed-meshheading:11401142-Animals,
pubmed-meshheading:11401142-Blood Platelets,
pubmed-meshheading:11401142-Coronary Thrombosis,
pubmed-meshheading:11401142-Dipyridamole,
pubmed-meshheading:11401142-Dogs,
pubmed-meshheading:11401142-Drug Therapy, Combination,
pubmed-meshheading:11401142-Nitric Oxide,
pubmed-meshheading:11401142-Phosphodiesterase Inhibitors,
pubmed-meshheading:11401142-Purinones,
pubmed-meshheading:11401142-Thrombolytic Therapy
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Cessation of platelet-mediated cyclic canine coronary occlusion after thrombolysis by combining nitric oxide inhalation with phosphodiesterase-5 inhibition.
|
|
pubmed:affiliation |
Department of Anesthesia and Critical Care, Cardiovascular Research Center, Massachusetts General Hospital and Harvard Medical School, Boston 02114, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
